US Stock MarketDetailed Quotes

SPRY ARS Pharmaceuticals

Watchlist
  • 11.430
  • +0.090+0.79%
Close Jan 8 16:00 ET
1.11BMarket Cap-22.86P/E (TTM)

ARS Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ARS Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 17.028M--
--2024/Q4-- / 17.077M--
Nov 13, 20242024/Q32.068M / 575.000K--
--2024/Q2500.000K / 666.670K--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 17.028M--
--2024/Q4-- / 17.077M--
Nov 13, 20242024/Q32.068M / 575.000K--
--2024/Q2500.000K / 666.670K--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

ARS Pharmaceuticals Earnings Reports

  • ARS Pharmaceuticals | 10-Q/A: Quarterly report (Amendment)

    Dec 6, 2024 16:10 ET

  • ARS Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 13, 2024 07:08 ET

  • ARS Pharmaceuticals | 8-K: ARS Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Updates

    Nov 13, 2024 07:03 ET

  • ARS Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 6, 2024 16:12 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 31, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data